Assignee
ABBVIE GLOBAL ENTPR LTD
BM·1 granted patent·4 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
5 records- 0159US2024043386A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2023·Application pending·0 cites
- 0256US2022281857A1Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2022·Application pending·0 cites
- 0355US11345691B2Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE GLOBAL ENTPR LTD·Filed 2020·Granted May 31, 2022·0 cites·3 claims
- 0452US2022213041A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
- 0545US2022211692A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABBVIE GLOBAL ENTPR LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →